|
   |
|
LETTER TO EDITOR |
|
|
|
| Year : 2014 | Volume
: 35
| Issue : 1 | Page : 75-76 |
| |
Sinecatechins: A better prospect for treating anogenital warts
Govindan Balaji
Department of Sexually Transmitted Diseases, Govt Mohan Kumaramangalam Medical College Hospital, Salem, Tamil Nadu, India
| Date of Web Publication | 13-May-2014 |
Correspondence Address:
Govindan Balaji
Department of Sexually Transmitted Diseases, Govt Mohan Kumaramangalam Medical College Hospital, Salem - 636 001, Tamil Nadu
India
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/0253-7184.132415
How to cite this article:
Balaji G. Sinecatechins: A better prospect for treating anogenital warts. Indian J Sex Transm Dis 2014;35:75-6 |
Sir,
Anogenital warts are the skin tumours caused by human papilloma virus (HPV) that may bother both the patients and their partners. Current treatment options are not satisfactory due to low efficacy and high recurrence rates. Although prophylactic vaccines have been recommended for adolescent women, more effective treatment modalities for anogenital warts are still needed.
Topical Sinecatechins Ointment 15% is the first FDA approved botanical drug for treating anogenital warts. [1] Sinecatechins are a standardized extract of green tea leaves from Camellia sinensis, a species of the Theaceae family, containing polyphenols; particularly catechins (more than 85%). It contains eight different catechins and other green tea components. The main catechin in sinecatechins ointment his epigallocatechin gallate (EGCG), which has the highest biological activity. [2]
Catechins exert multiple biologic activities by inhibiting a number of proteins, including enzymes involved in oxidative stress, blocking the kinases needed in tumour cell signalling and induction of apoptosis. These postulated mechanisms presumably contribute to the therapeutic effect of sinecatechins ointment.
The proposed mechanisms of action of sinecatechins are:
Anti-oxidant activity
The direct action of catechins is scavenging the reactive oxygen free radicals. Catechins may exert indirect antioxidant activity via inhibitory effects on transcription factors (e.g., nuclear factor-kB [NF-kB], activator protein-1 [AP-1]) and also inhibits the enzymes with activity that increases oxidative stress (e.g., lipoxygenases, cycloxygenases, and inducible nitric oxide). [3] EGCG also induces expression of endogenous antioxidant systems.
Anti-proliferative activity
HPV E6 (early gene E6) degrades p53 (a tumour suppressor gene), inhibits the pro-apoptotic protein BAK, activates telomerase and stabilizes Src-family kinases. HPV E7 (early gene E7) inactivates Rb (a tumour suppressor gene).
Conventionally, the Rb inhibits cell proliferation by binding to the E2F transcription factor (which controls the G1/S phase checkpoint of the cell cycle). Degradation of Rb by HPV E7 can result in uncontrolled cell division. A normal cell would react to this excessive cell division by p53-dependent apoptosis; but the presence of HPV E6 prevents apoptosis by deactivation of p53 and BAK. The end result of their combined action (E6, E7) is cellular proliferation. [4] Catechins check the proliferation of cells by inhibiting kinases (receptor tyrosine kinases, telomerase) and promoting apoptosis.
Immuno-stimulatory activity
HPV evades the immune system by reducing the expression of viral proteins in the immunogenic lower epithelial layers and decreased production of interferons. Catechins increase the activation of macrophages, lymphocytes, Langerhans cells and induction of cytokines (IL-1β, TNF-α, IFN-γ), thereby eliciting cell-mediated immunity against HPV.
To conclude, not only has the sinecatechins had a wide spectrum of action but also the low recurrence rate (6.5%). [5] Hence, it could be a better option to treat anogenital warts in future.
 References | |  |
| 1. | Somesh Gupta, Bushan Kumar. Anogenital warts, Intraepithelial Neoplasia, and their Clinical Management. In: Sexually Transmitted Infections. 2 nd ed.. New Delhi: Elsevier; 2012. p. 371. 
|
| 2. | Rosen T. Green tea catechins: Biologic properties, proposed mechanisms of action and clinical implications. J Drugs Dermatol 2012;11:e55-60.
|
| 3. | Tyring SK. Sinecatechins: Effects on HPV-Induced Enzymes Involved in Inflammatory Mediator Generation. J Clin Aesthet Dermatol 2012;5:19-26.
|
| 4. | Malik AI. The role of Human papilloma virus in the aetiology of Cervical Cancer. J Pak Med Assoc 2005;55:553-8.
|
| 5. | Tatti S, Swinehart JM, Thielert C, Tawfik H, Mescheder A, Beutner KR. Sinecatechins, a defined green tea extract, in the treatment of external anogenital warts: A randomized controlled trial. Obstet Gynecol 2008;111:1371-9.
|
| This article has been cited by | | 1 |
Assessment of sinecatechins 10% ointment used as proactive sequential therapy in recurrence rate of genital warts lesions after cryotherapy. The PACT-II Trial (postablation immunomodulator treatment of condylomata with sinecatechins): a prospective assess |
|
| Valeria GASPARI, Elisa CINOTTI, Mario PUVIANI, Emanuele TROVATO, Marco CAMPOLI, Massimo MILANI | | Italian Journal of Dermatology and Venereology. 2022; 157(1) | | [Pubmed] | [DOI] | | | 2 |
Antibiotic resistance modifying ability of phytoextracts in anthrax biological agent Bacillus anthracis and emerging superbugs: a review of synergistic mechanisms |
|
| Mackingsley Kushan Dassanayake, Teng-Jin Khoo, Jia An | | Annals of Clinical Microbiology and Antimicrobials. 2021; 20(1) | | [Pubmed] | [DOI] | |
|
|
|
|
